This study aims to investigate the possible role of CHRM3-targeted miRNAs using 2 human colon cancer cell lines: H508 strong-expressing CHMR3 and SNU-C4 weak-expressing CHRM3. This evidence concerns the gene CHRM3 and malignant colon neoplasm.